Affiliations 

  • 1 Consultant Neonatologist Hospital Pakar Sultanah Fatimah, Jalan Salleh Muar, 84000 Muar, Johor, E-mail: angelinewsl@yahoo.com/angelinewsl@gmail.com
  • 2 Family Medicine Specialist Klinik Kesihatan Changloon Jitra, Kubang Pasu, 06010 Changloon, Kedah, E-mail: drsuz67@yahoo.com.my
  • 3 Consultant Paediatrician Hospital Miri, Jalan Cahaya Miri, 98000 Miri, Sarawak, E-mail: tehshean@gmail.com
  • 4 Senior Lecturer & Consultant Neonatologist, Pusat Perubatan Universiti Malaya, Lembah Pantai, 59100 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, E-mail: yaomun@um.edu.my
  • 5 Consultant Neonatologist Hospital Serdang, Jalan Puchong Kajang, 43000 Kajang, Selangor, E-mail: dfuzzy@gmail.com
Malays Fam Physician, 2016;11(2-3):16-19.
PMID: 28461853

Abstract

The Clinical Practice Guidelines on Management of Neonatal Jaundice 2003 was updated by a multidisciplinary development group and approved by the Ministry of Health Malaysia in 2014. A systematic review of 13 clinical questions was conducted using evidence retrieved mainly from Medline and Cochrane databases. Critical appraisal was done using the Critical Appraisal Skills Programme checklist. Recommendations were formulated based on the accepted 103 evidences and tailored to local setting as stated below. Neonatal jaundice (NNJ) is a common condition seen in primary care. Multiple risk factors contribute to severe NNJ, which if untreated can lead to adverse neurological outcomes. Visual assessment, transcutaneous bilirubinometer (TcB) and total serum bilirubin (TSB) are the methods used for the detection of NNJ. Phototherapy remains the mainstay of the treatment. Babies with severe NNJ should be followed-up to detect and manage sequelae. Strategies to prevent severe NNJ include health education, identification of risk factors, proper assessment and early referral.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.